Global Polymerase Chain Reaction (PCR) Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 8.2% during forecast period.
Global Polymerase Chain Reaction (PCR) Market Overview:
Polymerase chain reaction (PCR) is a widely used method for rapidly producing millions to billions of copies (full or partial copies) of a specific DNA sample, allowing scientists to take a small sample of DNA and amplify it (or a portion of it) to a big enough amount to investigate in depth.
Global Polymerase Chain Reaction (PCR) Market Dynamics:
Rising prevalence of chronic and infectious diseases over the past decade is the major driving factor for market growth.
One of the primary factors driving the market’s growth is the rising frequency of numerous infectious diseases and genetic disorders. The growing global geriatric population, which is more susceptible to chronic medical diseases, is also propelling the market forward. The increased need for advanced diagnostic techniques, prenatal genetic testing procedures, and the growing number of CROs, forensic and research laboratories is one of the primary drivers driving the market, owing to its accuracy, automation, precision, real-time quantification, and sensitivity. The increasing demand in the clinical diagnostic area of the industry has a positive impact on the PCR industry. Because viral culture tests are not recommended by the government, practically all diagnostic tests use RT-PCR to test people who have COVID 19 symptoms and are urged by healthcare providers to get tested.
Furthermore, the growing availability of government financing for genomics research is expected to accelerate market growth. For example, Genomes Medicine Ireland (GMI) received USD 413.91 million in funding in 2018 to pursue genomics research in Ireland. The researchers were able to apply their findings to more than 60 different diseases as a result of this. Biotechnology and pharmaceutical companies are experimenting with genomic medicine and direct-to-consumer genetic testing to acquire a competitive advantage in the developing field of customized medicine. To create these items, the industry is accelerating the R&D process in biotechnology, which is where the polymerase chain reaction has the most applicability. Miniaturization of the polymerase chain reaction method might open up new opportunities for polymerase chain reaction technologies globally. In the worldwide polymerase chain reaction technologies market, new product launches are a current market trend.
The report has profiled twenty key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
Global Polymerase Chain Reaction (PCR) Market Segment Analysis:
The Global Polymerase Chain Reaction (PCR) Market is segmented on the basis of Product, Application and End-Users.
Based on Product, the instruments segment accounted for the largest market share in 2019. The increased popularity of qPCR and dPCR due to their faster detection of diseases and pathogens, as compared to conventional technologies, is one of the causes driving this segment’s dominance. Higher sensitivity and resolution, the ability to automate, and widespread use of gene expression analysis and genotyping as a validation tool are all characteristics that benefit this category. Instruments such as Thermo Fisher Scientific, Inc.’s QuantStudio 3 & 5 Real-Time PCR Systems, as well as Thermo Fisher Scientific, Inc.’s 7500 Fast & 7500 Real-Time PCR System; Bio-Rad Laboratories, Inc.’s QuantStudio 3D dPCR System & CFX96; Roche Molecular Systems, Inc.’s SmartCycler by Cepheid, Rotor-Gene Q are widely available. Specificity, sensitivity, and automation are among the benefits afforded by these instruments during the development of point-of-care diagnostics.
Based on Application, the clinical diagnostics segment is expected to dominate the global market during the forecast period. The need for PCR in clinical diagnostic laboratories and hospitals is expected to boost. Through forecast years, the segment is expected to grow at an annual rate of 8.5%. Infectious disorders, cancer, and congenital anomalies are among areas where PCR-based molecular diagnostic assays are increasingly being employed to guide patient therapy. The frequency of genetic, infectious, and chronic diseases is increasing worldwide, and this, combined with the growing availability of genetic and genomic information, has prompted the rapid adoption of PCR techniques in clinical laboratories. The escalating number of COVID-19 cases and the disease’s spread in major nations has increased the demand for virus diagnostic testing among the suspected population. This is mostly owing to the scarcity or non-existence of speedy or specific diagnostic diagnostics for these disorders.
Global Polymerase Chain Reaction (PCR) Market
To know about the Research Methodology :- Request Free Sample Report
Global Polymerase Chain Reaction (PCR) Market Regional Insights:
Global Polymerase Chain Reaction (PCR) Market 1
North America is expected to dominate the global market during forecast period.
Because of favourable government initiatives, flexible regulatory requirements, a growing number of diagnostics product launches, and emergency use of diagnostics for COVID-19 detection in the region, North America dominates the polymerase chain reaction market. The key drivers driving the market’s growth include the increased frequency of genetic and chronic illnesses such as cancer, the ageing population, the increased need for precision and personalised medicine, and favourable government initiatives. COVID-19 instances are fast increasing, and the virus is spreading at a breakneck pace, hastening the spread of the infection. As the number of suspects grows, so does the number of diagnostic tests, enhancing the country’s market growth. For example, the Department of Health and Human Services authorised the use of diagnostics for the identification of COVID-19 in an emergency situation in February 2020. The number of diagnostics products launched in the region grew as a result of this approval.
The report also helps in understanding Global Polymerase Chain Reaction (PCR) Market dynamics, structure by analyzing the market segments and project the Global Polymerase Chain Reaction (PCR) Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Polymerase Chain Reaction (PCR) Market make the report investor’s guide.
Global Polymerase Chain Reaction (PCR) Market, Key Developments:
• To fulfill the growing global demand for COVID-19 testing, Thermo Fisher Scientific Inc. released a new highly automated, real-time PCR solution in August 2020. It can analyse up to 6,000 samples in a single day.
• Azure Biosystems will release the Azure Cielo Real-time PCR instrument in June 2020. The Azure 96-well qPCR machine delivers on the Azure brand promise of excellent performance, small design, and simple workflow.
Global Polymerase Chain Reaction (PCR) Market Scope: Inquire before buying
Global Polymerase Chain Reaction (PCR) Market 2
Global Polymerase Chain Reaction (PCR) Market, By Region:
• North America
• South America
Global Polymerase Chain Reaction (PCR) Market, Key players:
• Thermo Fisher Scientific Inc.
• Sygnis AG, LGC Ltd
• Bio-Rad Laboratories Inc.
• Agilent Technologies, Inc.
• BioMerieux S.A.
• RainDance Technologies, Inc.
• Affymetrix Inc.
• Fluidigm Corporation
• Takara Bio Inc.
• Beckman Coulter
• Becton, Dickinson and Company
• Clontech Laboratories
• GE Healthcare
• Kapa Biosystems
• Maxim Biotech
• Siemens Healthcare
About This Report
This Report Is Submitted By : Maximize Market Research Company
Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.